Praktyczne zastosowanie map z-score dopasowanych do wieku z dużej normatywnej bazy danych pediatrycznych PET-FDG w lokalizowaniu nieprawidłowości epileptogennych: przypadki ilustracyjne

Preprint (medRxiv/bioRxiv)➕ 28.09.2026Preprint (medRxiv/bioRxiv)

Clinical utility of age-matched z-score maps from a large normative pediatric [18F]-FDG PET database for localizing epileptogenic abnormalities: illustrative cases

W skrócie

[Preprint - wstępne wyniki] Badacze stworzyli dużą bazę danych zdrowych dzieci i młodzieży (0-19 lat) przeskanowanych metodą PET-FDG mózgu, aby lepiej interpretować wyniki u dzieci z epilepsją. Opracowali mapy porównawcze dostosowane do wieku dziecka, które wskazują obszary mózgu z nieprawidłowym metabolizmem glukozy i mogą pomóc w identyfikacji źródła napadów epilepsji. Na przykładach pacjentów z epilepsją wykazali, że ta metoda może wychwycić nieprawidłowości związane z różnymi przyczynami epilepsji, uzupełniając tradycyjną ocenę lekarza.

Oryginalny abstract (angielski)

Abstract Introduction Quantitative interpretation of pediatric brain [ 18 F]-FDG PET is limited by the lack of age-matched normative reference databases, despite substantial developmental variation in cerebral glucose metabolism. This study aimed to construct a large-scale normative pediatric [ 18 F]-FDG PET database and develop an age-specific z-score mapping framework for quantitative evaluation of pediatric epilepsy. Method Pediatric brain PET data were retrospectively derived from clinically acquired whole-body or dedicated [ 18 F]-FDG PET examinations in participants 0–19 years of age without neurologic disease or visible brain abnormalities. A total of 417 PET scans from 341 participants were stratified into five developmental age groups: infancy, early childhood, middle childhood/school age, adolescence, and late adolescence. SUVR maps were generated using whole-brain atlas and brainstem reference regions. Voxel-wise t-test analyses were performed to characterize age- and sex-related metabolic differences. Age-specific voxel-wise mean and standard deviation maps were generated from the normative cohort and used to calculate age-matched hypometabolic z-score maps in 14 pediatric patients with epilepsy. The resulting abnormalities were qualitatively evaluated for concordance with epileptogenic findings identified on clinical MRI and/or PET by expert image review. Results Voxel-wise analyses demonstrated prominent age-dependent SUVR differences, particularly between infancy and older age groups. With whole-brain atlas normalization, older children showed progressively higher relative SUVR in cortical and cerebellar gray matter regions, whereas infancy showed relatively higher SUVR in the occipital cortex, white matter, thalamus, and brainstem. Brainstem normalization produced distinct developmental patterns, emphasizing higher white matter SUVR in infancy and broader gray matter differences in older groups. Sex-related differences were limited and regionally specific. Whole-brain atlas normalization showed lower variability than brainstem normalization and was selected for z-score mapping. In representative epilepsy cases, age-matched z-score maps identified focal or regional hypometabolism corresponding to malformations of cortical development, focal cortical dysplasia, mesial temporal sclerosis, nonlesional MRI cases, remote insult, tumor-related abnormalities, and Sturge-Weber syndrome. Discussion A large-scale normative pediatric [18F]-FDG PET database can support developmentally appropriate quantitative interpretation of pediatric brain PET. Age-matched z-score mapping may complement visual assessment by highlighting abnormal cerebral glucose metabolism in pediatric epilepsy, although findings should be interpreted with MRI, EEG, seizure semiology, and other presurgical data.

Metadane publikacji

Journal
Preprint (medRxiv/bioRxiv)
Data publikacji
24.09.2026
DOI
10.21203/rs.3.rs-11143642/v1
Europe PMC ID
PPR1326653
Autorzy
Lim S, Min PH, Dizdar N, Diaz MD, Guerin JB, Silvera M, Wong-Kisiel LC, Salehinejad H, Bilgin GB, Bilgin C
Źródło
Preprint (medRxiv/bioRxiv)